Patent application number | Description | Published |
20080214674 | ACYLHYDRAZONE DERIVATIVES AND THE USE THEREOF IN THE INHIBITION, REGULATION AND/OR MODULATION OF KINASE SIGNAL TRANSDUCTION - Acylhydrazone derivatives of the formula (I) are SGK inhibitors and can be used for the treatment of SGK-induced diseases and conditions, such as diabetes, obesity, metabolic syndrome (dyslipidaemia), systemic and pulmonary hypertonia, cardiovascular diseases and renal diseases, generally in any type of fibrosis and inflammatory process. In which R | 09-04-2008 |
20100331338 | Glucokinase Activators - Novel compounds of the Formula (I) in which R | 12-30-2010 |
20110009455 | 5-Oxo-2,3,4,5-tetrahydro-benzo[b]oxepine-4-carboxylic acid amides and 2,3-Dihydro-benzo[b]oxepine-4-carboxylic acid amides for treatment and prevention of Diabetes Typ 1 and 2 - The present invention relates to novel compounds of general formula (I) | 01-13-2011 |
20110028509 | Sulfonamides - The invention relates to compounds of formula I | 02-03-2011 |
20130225568 | TRIAZOLOPYRAZINE DERIVATIVES - Compounds of the formula I | 08-29-2013 |
20130225569 | FUROPYRIDINE DERIVATIVES - Compounds of the formula I | 08-29-2013 |
20150025058 | 8 - SUBSTITUTED 2 -AMINO - [1,2,4] TRIAZOLO [1, 5 -A] PYRAZINES AS SYK TRYROSINE KINASE INHIBITORS AND GCN2 SERIN KINASE INHIBITORS - Compounds of the formula I | 01-22-2015 |
20150038527 | FUROPYRIDINE DERIVATIVES - Compounds of the formula I | 02-05-2015 |